Insulin resistance has no impact on ghrelin suppression in pregnancy

Journal of Internal Medicine

Volumn 262, Issue 4, 2007, Pages 458-465

  Riedl, M ^a   Maier, C ^a   Handisurya, A ^a   Luger, A ^a   Kautzky Willer, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gestational diabetes mellitus; Ghrelin; Glucose metabolism; Insulin sensitivity; Pregnancy

Indexed keywords

GHRELIN; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; GENE REPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM;

ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES, GESTATIONAL; FASTING; FEMALE; HUMANS; INSULIN RESISTANCE; PEPTIDE HORMONES; PREGNANCY;

EID: 34548603165     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01832.x     Document Type: Article

References (43)

1. Granger JP. Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology. Am J Physiol Regul Integr Comp Physiol 2002 283 : R1289 92.
2. Buchanan TA. Glucose metabolism during pregnancy: normal physiology and implications for diabetes mellitus. Isr J Med Sci 1991 27 : 432 41.
3. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005 115 : 485 91.
4. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002 25 : 1862 8.
5. Mestman JH, Anderson GV, Guadalupe V. Follow-up study of 360 subjects with abnormal carbohydrate metabolism during pregnancy. Obstet Gynecol 1972 39 : 421 5.
6. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003 19 : 259 70.
7. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001 86 : 989 93.
8. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004 25 : 426 57.
9. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407 : 908 13.
10. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003 52 : 16 20.
11. Saad MF, Bernaba B, Hwu CM et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002 87 : 3997 4000.
12. Lucidi P, Murdolo G, Di Loreto C et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 2002 51 : 2911 4.
13. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50 : 1714 9.
14. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 : 707 9.
15. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003 52 : 2546 53.
16. Krohn K, Boczan C, Otto B et al. Regulation of ghrelin is related to estimated insulin sensitivity in obese children. Int J Obes (Lond) 2006 30 : 1482 7.
17. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004 89 : 1630 5.
18. Murdolo G, Lucidi P, Di Loreto C et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes 2003 52 : 2923 7.
19. Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA. 14-16 March 1997. Diabetes Care 1998 21 Suppl 2 : B1 167.
20. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001 24 : 539 48.
21. Bo S, Signorile A, Menato G et al. C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 2005 28 : 779 86.
22. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 107 : 391 7.
23. Fuglsang J, Skjaerbaek C, Espelund U et al. Ghrelin and its relationship to growth hormones during normal pregnancy. Clin Endocrinol (Oxf) 2005 62 : 554 9.
24. Fuglsang J, Sandager P, Moller N, Fisker S, Frystyk J, Ovesen P. Peripartum maternal and foetal ghrelin, growth hormones, IGFs and insulin interrelations. Clin Endocrinol (Oxf) 2006 64 : 502 9.
25. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 : 656 60.
26. Lacroix MC, Guibourdenche J, Frendo JL, Muller F, Evain-Brion D. Human placental growth hormone-a review. Placenta 2002 23 : Suppl A.
27. Cappiello V, Ronchi C, Morpurgo PS et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 2002 147 : 189 94.
28. Eden Engstrom B, Burman P, Holdstock C, Karlsson FA. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 2003 88 : 5193 8.
29. Maier C, Schaller G, Buranyi B et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 2004 89 : 4729 33.
30. Gauna C, Meyler FM, Janssen JA et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004 89 : 5035 42.
31. Ariyasu H, Takaya H, Hosoda H et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 2002 143 : 3341 50.
32. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002 87 : 2988.
33. Gaytan F, Barreiro ML, Chopin LK et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003 88 : 879 87.
34. Gaytan F, Barreiro ML, Caminos JE et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 2004 89 : 400 9.
35. Fernandez-Fernandez R, Tena-Sempere M, Navarro VM et al. Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinology 2005 82 : 245 55.
36. Tena-Sempere M, Barreiro ML, Gonzalez LC et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002 143 : 717 25.
37. Fernandez-Fernandez R, Navarro VM, Barreiro ML et al. Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat. Endocrinology 2005 146 : 3018 25.
38. Kawamura K, Sato N, Fukuda J et al. Ghrelin inhibits the development of mouse preimplantation embryos in vitro. Endocrinology 2003 144 : 2623 33.
39. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003 23 : 7973 81.
40. Qader SS, Lundquist I, Ekelund M, Hakanson R, Salehi A. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regul Pept 2005 128 : 51 6.
41. Dezaki K, Hosoda H, Kakei M et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 2004 53 : 3142 51.
42. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002 146 : 241 4.
43. Patel AD, Stanley SA, Murphy KG et al. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Pept 2006 134 : 17 22.